Published in Ann Intern Med on January 01, 1988
The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging (2010) 2.69
Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation (2009) 1.75
Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? Cardiovasc Ultrasound (2005) 1.67
The intersection between aging and cardiovascular disease. Circ Res (2012) 1.61
Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart (2002) 1.58
Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ (1994) 1.46
Hemodynamic and echocardiographic profiles in African American compared with White offspring of hypertensive parents: the HyperGEN study. Am J Hypertens (2013) 1.43
Caloric restriction: powerful protection for the aging heart and vasculature. Am J Physiol Heart Circ Physiol (2011) 1.35
Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich) (2011) 1.32
Helicobacter pylori infection in healthy people: a dynamic process? Gut (1991) 1.31
A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. J Clin Invest (1998) 1.27
Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2009) 1.22
Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ (1998) 1.19
Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy. J Biomed Biotechnol (2010) 1.14
Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile. J Thorac Cardiovasc Surg (2009) 1.09
Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham heart study. Circulation (2009) 1.04
Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond Engl) (2010) 1.02
Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study. Drugs (1988) 1.01
Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients? Br J Gen Pract (2000) 1.01
The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern. JACC Cardiovasc Imaging (2014) 1.01
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol (2011) 0.98
Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail (2009) 0.98
Echocardiographic left ventricular mass index predicts incident stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study. Stroke (2007) 0.96
Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis. Clin Res Cardiol (2010) 0.92
Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress. J Cardiovasc Magn Reson (2009) 0.91
Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart (1997) 0.90
Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality. Cardiovasc Drugs Ther (1994) 0.89
Effects of body size and body fatness on left ventricular mass in children and adolescents: Project HeartBeat! Am J Prev Med (2009) 0.88
Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow? Heart Fail Rev (2006) 0.88
Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus. Cardiovasc Diabetol (2003) 0.88
Cellular mechanisms of cardiac hypertrophy. Br Heart J (1995) 0.88
Adverse vascular risk is related to cognitive decline in older adults. J Alzheimers Dis (2015) 0.87
The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms. Circ Res (2016) 0.87
Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies. Heart Fail Rev (2007) 0.85
Impact of prehypertension on left ventricular structure, function and geometry. J Clin Diagn Res (2014) 0.85
Mechanisms underlying hemodynamic and neuroendocrine stress reactivity at different phases of the menstrual cycle. Psychophysiology (2014) 0.84
Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol (2015) 0.83
Heart failure in the twenty-first century: is it a coronary artery disease or hypertension problem? Cardiol Clin (2007) 0.82
Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone. J Am Heart Assoc (2014) 0.81
Secular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study. Heart (2013) 0.80
Comparison of radiological findings of chest x-ray with echocardiography in determination of the heart size. Iran Red Crescent Med J (2015) 0.80
Intradialytic hypotension and cardiac remodeling: a vicious cycle. Biomed Res Int (2015) 0.80
Adaptive and genetic alterations of the renin angiotensin system in cardiac hypertrophy and failure. Basic Res Cardiol (1996) 0.79
Management of Hypertension among Patients with Coronary Heart Disease. Int J Hypertens (2011) 0.79
Shorter height is related to lower cardiovascular disease risk - a narrative review. Indian Heart J (2012) 0.78
Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension. Am J Hypertens (2010) 0.78
Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study. Cardiovasc Ultrasound (2006) 0.78
Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients. BMC Cardiovasc Disord (2014) 0.78
Left ventricular hypertrophy after hypertensive pregnancy disorders. Heart (2015) 0.78
Asymptomatic obese hypertensives and need of routine echocardiography for left ventricular mass assessment and treatment. J Clin Diagn Res (2013) 0.77
Heart failure in acute ischemic stroke. Curr Cardiol Rev (2010) 0.77
Pharmacological Strategies to Retard Cardiovascular Aging. Circ Res (2016) 0.76
New paradigms in preventive cardiology: unconventional coronary risk factors. Ochsner J (2000) 0.76
Which measures of adiposity predict subsequent left ventricular geometry? Evidence from the Bogalusa Heart Study. Nutr Metab Cardiovasc Dis (2014) 0.76
Amlodipine as an antiischemic drug is superior to long acting nitrates. Open Med (Wars) (2014) 0.75
Telomere dynamics during aging in polygenic left ventricular hypertrophy. Physiol Genomics (2015) 0.75
Role of echocardiography in primary care medicine. Controversies in hypertension, atrial fibrillation, stroke, and endocarditis. West J Med (1996) 0.75
Mild and Short-Term Caloric Restriction Prevents Obesity-Induced Cardiomyopathy in Young Zucker Rats without Changing in Metabolites and Fatty Acids Cardiac Profile. Front Physiol (2017) 0.75
Einthoven Dissertation Prizes 2002. Neth Heart J (2003) 0.75
Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional study. Medicine (Baltimore) (2016) 0.75
Genetic association of left ventricular mass assessed by M-mode and two-dimensional echocardiography. J Hypertens (2016) 0.75
Obesity and the heart: cardiovascular magnetic resonance imaging evidence of the beneficial effects of bariatric surgery. JSLS (2013) 0.75
Moexipril and left ventricular hypertrophy. Vasc Health Risk Manag (2007) 0.75
The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. Liver Transpl (2014) 0.75
Reversibility of myocardial dyskinaesia due to severe hypertension. Postgrad Med J (1993) 0.75
Aortic unfolding determined using non-contrast cardiac computed tomography: correlations with age and coronary artery calcium score. PLoS One (2014) 0.75
Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice. Biochem Biophys Res Commun (2015) 0.75
Impact of prehypertension on left ventricular mass and QT dispersion in adult black Nigerians. Cardiovasc J Afr (2014) 0.75
Cardiovascular, hemodynamic, neuroendocrine, and inflammatory markers in women with and without vasomotor symptoms. Menopause (2016) 0.75
Factors Contributing to Development and Reversal of LVH: A Pilot Study. J Clin Diagn Res (2016) 0.75
[Standard-ECG]. Herzschrittmacherther Elektrophysiol (2008) 0.75
Normative Left Ventricular M-Mode Echocardiographic Values in Preterm Infants up to 2 kg. J Am Soc Echocardiogr (2017) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation (1989) 9.97
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol (2000) 4.48
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation (1977) 4.47
The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med (1970) 4.11
Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
Epidemiology of coronary heart disease: the Framingham study. Am J Med (1984) 3.38
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15
The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med (1969) 2.88
The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol (1980) 2.86
Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med (1987) 2.82
Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet (1974) 2.81
Labile hypertension: a faulty concept? The Framingham study. Circulation (1980) 2.76
Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation (1975) 2.74
Hearing in the elderly: the Framingham cohort, 1983-1985. Part I. Basic audiometric test results. Ear Hear (1990) 2.71
Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med (1985) 2.71
Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model. Biometrics (1992) 2.70
Clustering of metabolic factors and coronary heart disease. Arch Intern Med (1999) 2.69
Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68
Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet (1977) 2.66
High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis (1989) 2.65
Menopause and coronary heart disease. The Framingham Study. Ann Intern Med (1978) 2.62
Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med (1988) 2.62
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60